The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
Angela Su(Inserm), Alexandre Puissant(Délégation Paris 5), Raphaël Itzykson(Université Paris-Sud), Kimberly Stegmaier(Broad Institute), Bryann Pardieu(Centre National de la Recherche Scientifique), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Gaetano Sodaro(Centre National de la Recherche Scientifique), Camille Lobry(Inserm), Gabriela Alexe(Broad Institute), Camille Vaganay(Inserm), Lina Benajiba(Inserm), Kris C. Wood(Duke University), Iléana Antony‐Debré(Inserm), Frank Ling(Centre National de la Recherche Scientifique), Christopher F. Bassil(Duke University), Nina Fenouille(Délégation Paris 5), Justine Pasanisi(Centre National de la Recherche Scientifique), Jun Qi(Georgia Institute of Technology), Kevin Lin(The University of Texas MD Anderson Cancer Center), Yana Pikman(Broad Institute), Hava M. Golan, Jean‐François Benoist(Hôpital Robert-Debré), Justine C. Rutter(Duke University), Hervé Dombret(Université Paris Cité)
Cited by 5
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k